Navigation Links
Global Biopharma Mergers & Acquisition and Deal Making Report 2013: Understanding the Latest Trends to Optimize Future Strategy
Date:9/25/2013

DUBLIN, September 25, 2013 /PRNewswire/ --

Research and Markets
(http://www.researchandmarkets.com/research/ffq62m/biopharma_manda) has announced the addition of the "Biopharma M&A and Deal Making: Understanding the Latest Trends to Optimize Future Strategy" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The report, Biopharma M&A and Deal Making, was written to support team and corporate strategic initiatives around the options that exist to grow revenues through externalization, whether by M&A or licensing. CBR Pharma Insights provides in-depth analysis on the deals being done today, the trends being seen over time, and the strategies employed throughout the industry.

The leading pharmaceutical players continue to face the combined threats of a difficult operating environment and patent losses while struggling to deliver on pipeline potential. Externalization strategies are a key means to boost future revenues and, indeed more imminently, to satisfy shareholder demands. However, the increasing size of the leading biopharmaceutical companies is necessitating their involvement in growing the numbers and size of deals year by year. This in itself, along with the rising financial firepower of the mid-tier players, has increased the level of competition for the most attractive targets.

Increased competition in the marketplace for M&A and licensing deals can artificially inflate the cost of these deals, distorting the balance of value, risk and return. As a result companies must employ more rigorous selection processes and expand search criteria to consider more diverse options if they are to maximize their returns on investment.

Key Reasons to Purchase

- Understand and evaluate the strategies being used by companies of all sizes to support future revenue growth
- Benefit from CBR's case study analysis of the different types of deals being done in the current & future biopharma industry
- Access data and trends analysis of the types of deals taking place and which therapeutic areas are showing the most activity
- Gain insights around the steps that need to be taken in order to best secure a successful deal
- Learn who the key companies are to watch for in the coming year, the motivations behind the deals they are doing, and identify which ones relate to your business strategies

Key Topics Covered:

Chapter 1: Introduction
- What is driving the increased use of externalization in biopharma industry strategies
- Externalization strategies: the options
- Benefits of different deal types from M&A to arm's length licensing

Chapter 2: Trends in recent deal activity
- M&A deal trends
- Key acquisitions in 2012 and the motives behind them
- Most acquisitive companies
- Licensing deal trends (Type of deal, Therapy area, Phase)
- Divesting - the other extreme
- Focus on: Deal activity in the generics sector

Chapter 3: Successful deal making
- Key steps to successful deal making
- Shift to earlier stage deals
- Differentiating capabilities to position company as "partner of choice"
- Focus on: Joint ventures in emerging markets

Chapter 4: Future deal activity
- Key companies to watch in 2013

Appendix


For more information visit http://www.researchandmarkets.com/research/ffq62m/biopharma_manda.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Genomics Group (G3) and Illumina to Partner on Cardiovascular Genomics
2. Health Care Equipment & Supplies: Global Industry Guide
3. Sequenom Announces Global Certified Service Provider Program
4. InspireMD Appoints David Blossom as Vice President of Global Marketing and Strategy
5. Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes and Vials
6. Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging - Focus on Contract Packaging
7. Shire to Present at the Bank of America Merrill Lynch Global Health Care Conference
8. Synthetic Biologics to Present at the First Global Life Sciences Conference in Warsaw, Poland
9. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
10. Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference
11. Shire to Present at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):